Compare Aurora Cannabis Inc (ACB) vs Gogoro Inc (GGR) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

GGR trades at $3.94, down 0.51% today, with a bearish technical signal and negative profitability. The company reported a net loss of $79.97 million on $281.48 million revenue for 2025, though operating cash flow improved to $35.90 million. Recent news highlights a private placement and Q1 2026 results emphasizing margin improvements and growth initiatives.

The outlook remains challenging due to persistent losses and negative ROE, but low valuation multiples and projected cash flow improvements offer potential upside if execution improves. Key risks include sustained unprofitability and competitive pressures in the mobility sector.